Bliss GVS Pharma Limited (NSE:BLISSGVS)
India · Delayed Price · Currency is INR 436.55
+11.90 (2.80%)
Jun 11, 2026, 3:30 PM IST
Bliss GVS Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 11, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 46,129 | 12,386 | 11,793 | 7,421 | 7,978 | 10,181 | |
Market Cap Growth | 247.03% | 5.03% | 58.92% | -6.98% | -21.63% | -2.08% |
Enterprise Value | 45,052 | 11,511 | 11,487 | 7,314 | 7,890 | 10,302 |
Last Close Price | 436.55 | 117.15 | 111.75 | 70.01 | 75.35 | 95.88 |
PE Ratio | 42.28 | 14.69 | 15.63 | 10.47 | 53.05 | 14.86 |
PS Ratio | 5.31 | 1.53 | 1.53 | 0.99 | 1.07 | 1.76 |
PB Ratio | 3.95 | 1.13 | 1.18 | 0.81 | 0.94 | 1.23 |
P/TBV Ratio | 4.10 | 1.19 | 1.23 | 0.85 | 0.98 | 1.27 |
P/FCF Ratio | - | 41.50 | 15.83 | - | 12.98 | 18.56 |
P/OCF Ratio | - | 11.70 | 11.47 | 21.63 | 5.89 | 15.92 |
EV/Sales Ratio | 5.19 | 1.42 | 1.49 | 0.97 | 1.06 | 1.79 |
EV/EBITDA Ratio | 32.61 | 9.42 | 7.77 | 6.31 | 6.77 | 9.88 |
EV/EBIT Ratio | 41.78 | 11.83 | 9.25 | 7.42 | 7.79 | 11.52 |
EV/FCF Ratio | - | 38.56 | 15.42 | - | 12.83 | 18.78 |
Debt / Equity Ratio | 0.05 | 0.08 | 0.10 | 0.11 | 0.13 | 0.15 |
Debt / EBITDA Ratio | 0.38 | 0.70 | 0.66 | 0.87 | 0.92 | 1.14 |
Debt / FCF Ratio | - | 2.95 | 1.34 | - | 1.78 | 2.22 |
Net Debt / Equity Ratio | -0.13 | -0.05 | -0.04 | 0.04 | -0.03 | 0.07 |
Net Debt / EBITDA Ratio | -1.11 | -0.44 | -0.27 | 0.29 | -0.22 | 0.58 |
Net Debt / FCF Ratio | - | -1.78 | -0.54 | -0.56 | -0.42 | 1.10 |
Asset Turnover | - | 0.65 | 0.65 | 0.66 | 0.68 | 0.55 |
Inventory Turnover | - | 3.53 | 3.62 | 3.64 | 3.62 | 3.90 |
Quick Ratio | - | 3.45 | 3.55 | 2.38 | 2.32 | 2.66 |
Current Ratio | - | 4.81 | 5.15 | 3.61 | 3.33 | 3.76 |
Return on Equity (ROE) | - | 8.62% | 8.50% | 8.70% | 2.76% | 9.37% |
Return on Assets (ROA) | - | 4.84% | 6.56% | 5.44% | 5.79% | 5.31% |
Return on Invested Capital (ROIC) | 7.19% | 6.98% | 9.06% | 8.05% | 5.06% | 7.37% |
Return on Capital Employed (ROCE) | - | 8.60% | 11.80% | 10.20% | 11.60% | 10.20% |
Earnings Yield | 2.36% | 6.81% | 6.40% | 9.55% | 1.88% | 6.73% |
FCF Yield | - | 2.41% | 6.32% | -8.02% | 7.71% | 5.39% |
Dividend Yield | 0.23% | 0.43% | 0.45% | 0.71% | 0.66% | 0.52% |
Payout Ratio | - | 6.46% | 7.15% | 7.67% | 35.41% | 8.10% |
Buyback Yield / Dilution | -1.06% | 0.04% | -0.56% | -0.26% | 0.26% | -2.26% |
Total Shareholder Return | -0.83% | 0.46% | -0.11% | 0.45% | 0.93% | -1.74% |